Quantcast
 
New book by Larry Connors Click here Improve your trading - See how


 

Lagos First Lady Partners GSK On Cervical Cancer Prevention

Thu. November 05, 2009; Posted: 05:32 AM
Stocks RSS
Nov 05, 2009 (Daily Champion/All Africa Global Media via COMTEX) -- GSK | Quote | Chart | News | PowerRating -- LAGOS State First Lady, Mrs. Abimbola Fashola has commended multinational pharmaceutical company GlaxoSmithKline (GSK) for its leading role in the campaign against cervical cancer in Nigeria pledging that her office would work closely with the company to sustain the campaign and assist in making cervical vaccination more accessible to women to prevent current high incidence of the deadly disease in the country.

Receiving the company's management team led by the Managing Director, Mr. Lekan Asuni in her office at Ikeja recently, Mrs Fashola noted that the company's initiative, especially in the area of screening, vaccination and public awareness campaign would go a long way in alleviating the burden of cervical cancer on women in the state and Nigeria at large.

She disclosed that her office is working closely with the state government to develop a comprehensive programme for cervical cancer prevention, adding that this would also involve active collaboration with GSK and other stakeholders to ensure that more women benefit from the programme.

Mrs Fashola stressed the need for early detection and urged the company to intensify its awareness campaign particularly among young girls both in public and private schools while also urging the company to ensure that the vaccine is available and affordable so that more women and girls would be adequately protected against the scourge.

GSK Managing Director, Mr. Lekan Asuni in his response, thanked the First Lady for her commitment to the health and welfare of women in the state. According to him, GSK is the only pharmaceutical company licensed in Nigeria to market an Human Papillomavirus (HPV) vaccine that protects women against cervical cancer.

Based on this, he said, the company is currently embarking on a massive awareness campaign, capacity building for health professionals, provision of equipment for screening women against cervical cancer and the Human Papillomavirus (HPV), a sexually transmitted disease linked with up to 99 per cent of cervical cancer cases.

Mr. Asuni further commended the First Lady on her proposed project on cervical cancer prevention saying this would help in reducing the burden of the disease in the state. According to him, screening programmes have been acknowledged as effective in reducing the morbidity and mortality from cervical cancer. He pledged the company's support towards the success of the programme.

For full details on GlaxoSmithKline (GSK) click here. GlaxoSmithKline (GSK) has Short Term PowerRatings of 6. Details on GlaxoSmithKline (GSK) Short Term PowerRatings is available at This Link.

    


More News:   Market Updates | Stock Alerts | All Trading News | Stock Index

Email
Print
Archives
Feedback
Email Article Link
Close X
Recipients email address
Your name
Your email
Add a note (optional)




Stocks RSS





Related News [GSK]
  UPCOMING EVENTS
Learn new strategies, how to trade in this market, and the stocks you should be focusing on each day. Join us for our free 20 minute tele-seminars during the week.
* Attendance is strictly limited and are filled on a first-come, first-served basis.
PREMIER SPONSORED LINKS
TRADE CENTER
 
The TradingMarkets Directory
RELATED SITES
Nothing but forex
Please call 1-213-955-5858 ext. 1

About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback

Disclaimer:

The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.

It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.

HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.

The Connors Group, Inc.
10 Exchange Place, Suite 1800
Jersey City, NJ 07302

© Copyright 2009 The Connors Group, Inc.


All analyst commentary provided on TradingMarkets.com is provided for educational purposes only. The analysts and employees or affiliates of TradingMarkets.com may hold positions in the stocks or industries discussed here. This information is NOT a recommendation or solicitation to buy or sell any securities. Your use of this and all information contained on TradingMarkets.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy.

© 2009 The Connors Group, Inc.